Search
for
Sort by
Research 181–210 of 822
- Alternative treatment of polycystic ovary syndrome: pre-clinical and clinical basis for using plant-based drugs
- Evidence-based approach to cutaneous hyperandrogenism in women
- Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism
- Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?
- Redefining hormone resistance in prostate cancer
- Leydig Cell Hyperplasia and Adenomas in Mice Treated with Finasteride, a 5α-Reductase Inhibitor: A Possible Mechanism
- Pharmacotherapy of polycystic ovary syndrome - an update
- The Efficacy of 24-Month Metformin for Improving Menses, Hormones, and Metabolic Profiles in Polycystic Ovary Syndrome
- Gender-Affirming Hormone Therapy for Transgender Females
- Understanding and Addressing Hair Disorders in Transgender Individuals
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Controversies Regarding Transdermal Androgen Therapy in Postmenopausal Women
- Significant effects of mild endogenous hormonal changes in humans: considerations for low-dose testing.
- Nonclassic congenital adrenal hyperplasia
- Clinical applications of antiandrogens
- Management of CAH during pregnancy
- Gender-Affirming Hormone Therapy for Transgender Men
- Revisiting hyper- and hypo-androgenism by tandem mass spectrometry
- Polycystic ovarian syndrome
- Androgenetic Alopecia: In Vivo Models
- Hirsutism: diagnosis and treatment
- Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome
- Drug repositioning using <i>in silico</i> compound profiling
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Female Adolescent Hair Disorders
- Infertility Treatment in Polycystic Ovary Syndrome: Lifestyle Interventions, Medications and Surgery
- Chapter 17. Selective androgen receptor modulators (SARMs)
- Androgenic disorders of women: Diagnostic and therapeutic decision making
- Selenium and Polycystic Ovary Syndrome; Current Knowledge and Future Directions: A Systematic Review
- Candidate SNP markers of reproductive potential are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters